United Orthopedic Corporation (TPEX:4129)

Market Cap	10.08B +8.3%
Revenue (ttm)	5.46B +22.0%
Net Income	553.45M +21.9%
EPS	5.66 +19.7%
Shares Out	96.44M
PE Ratio	18.47
Forward PE	15.51
Dividend	4.00 (3.86%)
Ex-Dividend Date	Jul 23, 2025

Volume	113,907
Average Volume	208,507
Open	104.00
Previous Close	103.50
Day's Range	104.00 - 106.00
52-Week Range	77.30 - 131.50
Beta	0.46
RSI	35.94
Earnings Date	Mar 24, 2026

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee joints, including artificial knee replacement joints, revision knee replacement systems, restricted artificial knee joints, and customized artificia...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4129

Financial Performance

In 2024, United Orthopedic's revenue was 4.65 billion, an increase of 18.40% compared to the previous year's 3.93 billion. Earnings were 455.96 million, an increase of 20.11%.